OTCMKTS:GNGBY - GETINGE AB/ADR Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $11.4550 0.00 (0.00 %) (As of 02/17/2019 03:38 PM ET)Previous Close$11.4550Today's Range$11.4550 - $11.455052-Week Range$8.31 - $13.44Volume21 shsAverage Volume6,618 shsMarket Capitalization$2.91 billionP/E Ratio25.55Dividend Yield1.09%Beta1.83 ProfileDiscussionChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Getinge AB provides solutions for operating rooms, intensive-care units, sterilization departments, and life science companies and institutions. The company operates through Acute Care Therapies, Surgical Workflows, and Life Science segments. It offers anesthesia systems, acute care ventilation and hemodynamic monitoring, covered stents, aortic surgical and peripheral vascular grafts, thoracic drainage, surgery perfusion, extracorporeal life support, cardiac assist, endoscopic vessel harvesting systems, beating heart surgery products. The company also provides surgical tables and lamps, ceiling service units, wall modules, and hybrid operating rooms (OR); infection control products; integrated workflow solutions, including sterile supply management, patient flow optimization, and OR integration; and life science, such as sterilizers, cleaning and asepsis products, and isolators. It offers its products through a network of proprietary sales companies, as well as through agents and distributors in Europe, the Middle East, Africa, the Americas, Asia, and Pacific. The company has a strategic partnership with Verb Surgical Inc. to develop digital surgery solutions. Getinge AB was founded in 1904 and is headquartered in Gothenburg, Sweden. Receive GNGBY News and Ratings via Email Sign-up to receive the latest news and ratings for GNGBY and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:GNGBY Previous Symbol CUSIPN/A Webwww.getinge.com Phone46-1-033-500-00Debt Debt-to-Equity RatioN/A Current Ratio1.07 Quick Ratio0.63Price-To-Earnings Trailing P/E Ratio25.55 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$2.67 billion Price / Sales1.09 Cash Flow$2.2549 per share Price / Cash Flow5.08 Book Value$9.14 per share Price / Book1.25Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-106,910,000.00 Net Margins-3.88% Return on Equity-2.19% Return on Assets-1.02%Miscellaneous Employees10,700 Outstanding Shares254,150,000Market Cap$2.91 billion OptionableNot Optionable GETINGE AB/ADR (OTCMKTS:GNGBY) Frequently Asked Questions What is GETINGE AB/ADR's stock symbol? GETINGE AB/ADR trades on the OTCMKTS under the ticker symbol "GNGBY." How were GETINGE AB/ADR's earnings last quarter? GETINGE AB/ADR (OTCMKTS:GNGBY) posted its earnings results on Wednesday, January, 30th. The company reported $0.40 EPS for the quarter. The company had revenue of $908.63 million for the quarter. GETINGE AB/ADR had a negative return on equity of 2.19% and a negative net margin of 3.88%. View GETINGE AB/ADR's Earnings History. When is GETINGE AB/ADR's next earnings date? GETINGE AB/ADR is scheduled to release their next quarterly earnings announcement on Thursday, April 25th 2019. View Earnings Estimates for GETINGE AB/ADR. Has GETINGE AB/ADR been receiving favorable news coverage? Headlines about GNGBY stock have been trending negative recently, InfoTrie Sentiment reports. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. GETINGE AB/ADR earned a daily sentiment score of -2.8 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the near term. Who are some of GETINGE AB/ADR's key competitors? Some companies that are related to GETINGE AB/ADR include Masimo (MASI), LivaNova (LIVN), CONMED (CNMD), NxStage Medical (NXTM), Natus Medical (BABY), Viewray (VRAY), AxoGen (AXGN), BioLife Solutions (BLFS), Rockwell Medical (RMTI), Semler Scientific (SMLR), Cutera (CUTR), Helius Medical Technologies (HSDT), Electrocore (ECOR), Zynex (ZYXI) and Fonar (FONR). Who are GETINGE AB/ADR's key executives? GETINGE AB/ADR's management team includes the folowing people: Mr. Mattias Perjos M.Sc., CEO, Pres & Director (Age 47)Mr. Lars Sandström M.Sc., Chief Financial Officer (Age 47)Lars Mattsson, Head of Investor RelationsMs. Lena Hagman B.Sc., Exec. VP of Quality & Regulatory Compliance (Age 54)Mr. Abraham Ronai, Gen. Counsel How do I buy shares of GETINGE AB/ADR? Shares of GNGBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is GETINGE AB/ADR's stock price today? One share of GNGBY stock can currently be purchased for approximately $11.4550. How big of a company is GETINGE AB/ADR? GETINGE AB/ADR has a market capitalization of $2.91 billion and generates $2.67 billion in revenue each year. GETINGE AB/ADR employs 10,700 workers across the globe. What is GETINGE AB/ADR's official website? The official website for GETINGE AB/ADR is http://www.getinge.com. How can I contact GETINGE AB/ADR? GETINGE AB/ADR's mailing address is Lindholmspiren 7a Box 8861, Gothenburg V7, 402 72. The company can be reached via phone at 46-1-033-500-00 or via email at [email protected] MarketBeat Community Rating for GETINGE AB/ADR (OTCMKTS GNGBY)Community Ranking: 2.1 out of 5 ( )Outperform Votes: 39 (Vote Outperform)Underperform Votes: 54 (Vote Underperform)Total Votes: 93MarketBeat's community ratings are surveys of what our community members think about GETINGE AB/ADR and other stocks. Vote "Outperform" if you believe GNGBY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNGBY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/17/2019 by MarketBeat.com StaffFeatured Article: What Are Treasury Bonds?